Clopidogrel · larger labeled portfolio than Cannabidiol
SPL labels Clopidogrel + Cannabidiol as minor; Clopidogrel 10 / Cannabidiol 7 in that band.
Mechanism on file: Cannabidiol interferes with how your body activates clopidogrel, which can make the medicine less effective at preventing blood clots.
FDA SPL severity: Minor
Clopidogrel + Cannabidiol · SPL mechanism field
Cannabidiol interferes with how your body activates clopidogrel, which can make the medicine less effective at preventing blood clots.
Minor band excerpt · Clopidogrel with Cannabidiol
For CYP2C19 substrates (e.g., clopidogrel) where efficacy is mainly due to their active metabolite(s), concomitant use of EPIDIOLEX may decrease plasma concentration of the active metabolite(s) and may therefore decrease efficacy.
Clopidogrel · 19 SPL pairs (broader portfolio than Cannabidiol)
- Bupropion minor
- Dexlansoprazole minor
- Lansoprazole minor
- Morphine minor
Cannabidiol · 7 minor + 8 total pairs
- Digoxin minor
- Rifampin minor
- Tacrolimus Topical minor
- Theophylline minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.